IDEXX Laboratories Inc (BSP:I1DX34)
R$ 485.25 0 (0%) Market Cap: 200.38 Bil Enterprise Value: 203.84 Bil PE Ratio: 48.70 PB Ratio: 26.57 GF Score: 99/100

IDEXX Laboratories Inc at Raymond James Institutional Investors Conference Transcript

Mar 04, 2019 / 03:25PM GMT
John Wilson Ransom
Raymond James & Associates, Inc., Research Division - MD of Equity Research & Director of Healthcare Research

Good morning, everyone. Welcome to the Raymond James Institutional Investor Conference. I always find the energy -- mid-morning on Monday, the energy level is peaking. So this is a perfect time to introduce Jon Ayers of IDEXX. We hosted a dinner last night and probably one of the most entertaining and informative CEO dinners I've ever attended. So he's a firecracker. And a couple of -- you guys know all the standard stuff, but a couple of things that we noticed last night, I thought, were interesting: number one, stock's compounded at 21% since 2002. I went to Georgia, that's good, 21% is good. So phenomenal tenure. I've got a lot of CEOs that have been in the seat for a long time. I don't see some of the symptoms I see in other companies. This guy is still going 100 miles an hour. He is as fired up as he was. And so avoiding the CEO burnout and avoiding the distraction of doing dumb deals is harder to do than he thinks given the incentives. We talked about that. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot